Cargando…
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma
BACKGROUND: Cavernous angiomas (CAs) affect 0.5% of the population, predisposing to serious neurologic sequelae from brain bleeding. A leaky gut epithelium associated with a permissive gut microbiome, was identified in patients who develop CAs, favoring lipid polysaccharide producing bacterial speci...
Autores principales: | Srinath, Abhinav, Xie, Bingqing, Li, Ying, Sone, Je Yeong, Romanos, Sharbel, Chen, Chang, Sharma, Anukriti, Polster, Sean, Dorrestein, Pieter C., Weldon, Kelly C., DeBiasse, Dorothy, Moore, Thomas, Lightle, Rhonda, Koskimäki, Janne, Zhang, Dongdong, Stadnik, Agnieszka, Piedad, Kristina, Hagan, Matthew, Shkoukani, Abdallah, Carrión-Penagos, Julián, Bi, Dehua, Shen, Le, Shenkar, Robert, Ji, Yuan, Sidebottom, Ashley, Pamer, Eric, Gilbert, Jack A., Kahn, Mark L., D’Souza, Mark, Sulakhe, Dinanath, Awad, Issam A., Girard, Romuald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984539/ https://www.ncbi.nlm.nih.gov/pubmed/36869161 http://dx.doi.org/10.1038/s43856-023-00265-1 |
Ejemplares similares
-
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma
por: Polster, Sean P., et al.
Publicado: (2020) -
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
por: Shkoukani, Abdallah, et al.
Publicado: (2021) -
Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations
por: Koskimäki, Janne, et al.
Publicado: (2019) -
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
por: Shenkar, Robert, et al.
Publicado: (2022) -
Developmental venous anomalies are a genetic primer for cerebral
cavernous malformations
por: Snellings, Daniel A., et al.
Publicado: (2022)